(Q44811368)

6 December 2017

title

Development of a novel fusogenic viral liposome system (HVJ-liposomes) and its applications to the treatment of acquired diseases (English)

1 reference

6 December 2017

Kaneda Y

1

1 reference

6 December 2017

language of work or name

1 reference

1 January 1999

1 reference

Molecular Membrane Biology

6 December 2017

published in

1 reference

6 December 2017

volume

16

1 reference

6 December 2017

issue

1

1 reference

6 December 2017

page(s)

119-122

1 reference

Fusigenic viral liposome for gene therapy in cardiovascular diseases

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F096876899294841

Persistent gene expression in rat liver in vivo by repetitive transfections using HVJ-liposome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F096876899294841

Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F096876899294841

Development and characterization of cationic liposomes conjugated with HVJ (Sendai virus): reciprocal effect of cationic lipid for in vitro and in vivo gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F096876899294841

Sustained transgene expression in vitro and in vivo using an Epstein-Barr virus replicon vector system combined with HVJ liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F096876899294841

Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F096876899294841

21 January 2018

Identifiers

DOI

10.1080/096876899294841

1 reference

6 December 2017

1 reference